CYREN (CYRN) Reports Q3 Loss of $0.04
Tweet
Share
E-mailGet Alerts CYRN Hot Sheet
Join SI Premium – FREE
CYREN (NASDAQ: CYRN) reported Q3 EPS of ($0.04), versus ($0.02) reported last year. Revenue for the quarter came in at $6.9 million, versus $6.7 million reported last year.
For earnings history and earnings-related data on CYREN (CYRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
